| RS2474393026 |
HMX1
|
Health Risk |
Pathogenic |
Isolated microphthalmia 6, Isolated microphthalmia 6 |
| RS2474395788 |
OPA1
|
Health Risk |
Likely pathogenic |
Optic atrophy, Optic atrophy |
| RS2474395815 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2474424005 |
EVC
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS2474424607 |
EVC
|
Health Risk |
Pathogenic/Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2474462219 |
NKX3-2
|
Health Risk |
Pathogenic |
— |
| RS2474501996 |
CRYGS
|
Health Risk |
Likely pathogenic |
— |
| RS2474506697 |
EVC
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS2474507123 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2474507433 |
EVC
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS2474507585 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2474508277 |
EVC
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS2474508727 |
EVC
|
Health Risk |
Likely pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS2474512303 |
NSD2
|
Health Risk |
Likely pathogenic |
— |
| RS2474526523 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2474556395 |
DNAJB11
|
Health Risk |
Pathogenic |
Polycystic kidney disease 6 with or without polycystic liver disease, Polycystic kidney disease 6 with or without polycystic liver disease |
| RS2474564027 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS2474564704 |
EVC
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS2474564821 |
DNAJB11
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2474566006 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2474572635 |
RAB28
|
Health Risk |
Pathogenic |
— |
| RS2474574768 |
OPA1
|
Health Risk |
Pathogenic |
Autosomal dominant optic atrophy classic form, Autosomal dominant optic atrophy classic form |
| RS2474575339 |
OPA1
|
Health Risk |
Likely pathogenic |
Autosomal dominant optic atrophy classic form, Autosomal dominant optic atrophy classic form |
| RS2474576152 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2474576413 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2474576556 |
DNAJB11
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 6 with or without polycystic liver disease, Polycystic kidney disease 6 with or without polycystic liver disease |
| RS2474576718 |
OPA1
|
Health Risk |
Likely pathogenic |
OPA1-related disorder, OPA1-related disorder |
| RS2474576878 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2474578114 |
DNAJB11
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 6 with or without polycystic liver disease, Polycystic kidney disease 6 with or without polycystic liver disease |
| RS2474578222 |
OPA1
|
Health Risk |
Pathogenic |
OPA1-related disorder, OPA1-related disorder |
| RS2474580332 |
PIGG
|
Health Risk |
Likely pathogenic |
— |
| RS2474584542 |
OPA1;OPA1-AS1
|
Health Risk |
Pathogenic |
Optic atrophy with or without deafness, ophthalmoplegia |
| RS2474585323 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2474589841 |
TP63
|
Health Risk |
Likely pathogenic |
Auditory neuropathy, Auditory neuropathy |
| RS2474589927 |
TP63
|
Health Risk |
Likely pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS2474589968 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2474590664 |
TP63
|
Health Risk |
Likely pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS2474592385 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2474592669 |
RAB28
|
Health Risk |
Likely pathogenic |
Cone dystrophy, Cone dystrophy |
| RS2474598449 |
OPA1-AS1;OPA1
|
Health Risk |
Pathogenic |
Autosomal dominant cerebellar ataxia, Autosomal dominant cerebellar ataxia |
| RS2474599159 |
OPA1
|
Health Risk |
Pathogenic/Likely pathogenic |
OPA1-related disorder, OPA1-related disorder |
| RS2474599506 |
OPA1
|
Health Risk |
Likely pathogenic |
— |
| RS2474608949 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2474609100 |
TP63
|
Health Risk |
Likely pathogenic |
Ectrodactyly, ectodermal dysplasia |
| RS2474609177 |
TP63
|
Health Risk |
Pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS2474609185 |
TP63
|
Health Risk |
Likely pathogenic |
— |
| RS2474609250 |
TP63
|
Health Risk |
Likely pathogenic |
TP63-related disorder, TP63-related disorder |
| RS2474611174 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2474613656 |
TP63
|
Health Risk |
Pathogenic |
— |
| RS2474621465 |
NSD2
|
Health Risk |
Likely pathogenic |
Rauch-Steindl syndrome, Rauch-Steindl syndrome |
| RS2474621918 |
NSD2
|
Health Risk |
Pathogenic |
Rauch-Steindl syndrome, Rauch-Steindl syndrome |
| RS2474622067 |
NSD2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2474624136 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474624385 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474632246 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474632359 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474633301 |
NSD2
|
Health Risk |
Pathogenic |
Rauch-Steindl syndrome, Rauch-Steindl syndrome |
| RS2474635268 |
TP63
|
Health Risk |
Likely pathogenic |
Male infertility with spermatogenesis disorder, Male infertility with spermatogenesis disorder |
| RS2474638543 |
NSD2
|
Health Risk |
Pathogenic |
Rauch-Steindl syndrome, Rauch-Steindl syndrome |
| RS2474641210 |
PIGG
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2474656264 |
QDPR
|
Health Risk |
Pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS2474656314 |
EVC
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS2474656670 |
QDPR
|
Health Risk |
Pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS2474658353 |
QDPR
|
Health Risk |
Pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS2474659952 |
SEPSECS
|
Health Risk |
Likely pathogenic |
— |
| RS2474660058 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474660081 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474660169 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474660936 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474666866 |
EVC
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2474669849 |
NSD2
|
Health Risk |
Pathogenic |
— |
| RS2474671527 |
QDPR
|
Health Risk |
Likely pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS2474672497 |
EVC
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS2474673178 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474673222 |
EVC
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS2474673801 |
EVC
|
Health Risk |
Likely pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS2474675079 |
QDPR
|
Health Risk |
Pathogenic/Likely pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS2474678090 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474678156 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474680293 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474680377 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474680455 |
QDPR
|
Health Risk |
Pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS2474680524 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474680639 |
SEPSECS
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 2D, Pontocerebellar hypoplasia type 2D |
| RS2474683044 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474684351 |
QDPR
|
Health Risk |
Likely pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS2474687235 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474687418 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474687422 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474687748 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2474711823 |
TTN
|
Health Risk |
Likely pathogenic |
Centronuclear myopathy, Centronuclear myopathy |
| RS2474713494 |
TP63
|
Health Risk |
Conflicting classifications of pathogenicity |
TP63-Related Spectrum Disorders, Inborn genetic diseases |
| RS2474713721 |
TP63
|
Health Risk |
Pathogenic |
Premature ovarian failure 21, Premature ovarian failure 21 |
| RS2474713823 |
TP63
|
Health Risk |
Pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS2474714315 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Hematuria |
| RS2474716743 |
EVC
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS2474716865 |
EVC
|
Health Risk |
Likely pathogenic |
— |
| RS2474716928 |
EVC
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS2474717066 |
EVC
|
Health Risk |
Pathogenic/Likely pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS2474718308 |
COL4A4
|
Health Risk |
Pathogenic |
— |